On August 6, 2020, U.S. President Donald Trump issued an Executive Order whose expressed goal is bolstering domestic supply chains and reducing reliance on foreign manufacturers for Essential Medicines, Medical Countermeasures, and other Critical Inputs needed to make essential medicines.1 The Order also seeks to combat counterfeit Essential Medicines and Medical Countermeasures.
The Order states that “[i]t is critical that we reduce our dependence on foreign manufacturers …[,] ensure sufficient and reliable long-term domestic production of these products [and] … minimize potential shortages” in light of the threats posed by public health emergencies, such as the current COVID-19 pandemic.
Sidley Austin LLP provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship. Readers should not act upon this information without seeking advice from professional advisers.
Attorney Advertising—Sidley Austin LLP, One South Dearborn, Chicago, IL 60603. +1 312 853 7000. Sidley and Sidley Austin refer to Sidley Austin LLP and affiliated partnerships, as explained at www.sidley.com/disclaimer.
© Sidley Austin LLP